SERF Protein Is a Direct Modifier of Amyloid Fiber AssemblyFalsone, S. F., Meyer, N. H., Schrank, E., Leitinger, G., Pham, C. L. L., Fodero-Tavoletti, M. T., Holmberg, M., Dulle, M., Scicluna, B., Gesslbauer, B., Rueckert, H-M., Wagner, G. E., Merle, D. A., Nollen, E. A., Kungl, A. J., Hill, A. F., Cappai, R. & Zangger, K., Aug-2012, In : Cell reports. 2, 2, p. 358-371 14 p.
Research output: Contribution to journal › Article › Academic › peer-review
The inherent cytotoxicity of aberrantly folded protein aggregates contributes substantially to the pathogenesis of amyloid diseases. It was recently shown that a class of evolutionary conserved proteins, called MOAG-4/SERF, profoundly alter amyloid toxicity via an autonomous but yet unexplained mode. We show that the biological function of human SERF1a originates from its atypical ability to specifically distinguish between amyloid and nonamyloid aggregation. This inherently unstructured protein directly affected the aggregation kinetics of a broad range of amyloidogenic proteins in vitro, while being inactive against nonamyloid aggregation. A representative biophysical analysis of the SERF1a:alpha-synuclein (aSyn) complex revealed that the amyloid-promoting activity resulted from an early and transient interaction, which was sufficient to provoke a massive increase of soluble aSyn amyloid nucleation templates. Therefore, the autonomous amyloid-modifying activity of SERF1a observed in living organisms relies on a direct and dedicated manipulation of the early stages in the amyloid aggregation pathway.
|Number of pages||14|
|Publication status||Published - Aug-2012|
- CIRCULAR-DICHROISM SPECTROSCOPY, ALPHA-SYNUCLEIN AGGREGATION, PARKINSONS-DISEASE, FIBRIL FORMATION, IN-VITRO, OLIGOMERS, PATHWAY, NMR, MECHANISMS, DOPAMINE